Pfizer-BioNTech will soon request FDA emergency authorization for a second Covid booster shot for people 65 and older, a group for which the agency has previously been quick to approve new shots, the Washington Post reported.
Subscribe to:
Post Comments (Atom)
< + > Are You Experiencing Data Chaos or Clean Identity with Your EMPI?
Identity management is one of the most challenging problems healthcare IT organizations face. For those not familiar with identity manageme...
No comments:
Post a Comment